Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TLR2 Agonistic Small Molecules: Detailed Structure–Activity Relationship, Applications, and Future Prospects
Arshpreet Kaur, Deepender Kaushik, Sakshi Piplani, et al.
Journal of Medicinal Chemistry (2020) Vol. 64, Iss. 1, pp. 233-278
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Pattern recognition receptors in health and diseases
Danyang Li, Minghua Wu
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1003
The Role of TLR2 in Infectious Diseases Caused by Mycobacteria: From Cell Biology to Therapeutic Target
Wanbin Hu, Herman P. Spaink
Biology (2022) Vol. 11, Iss. 2, pp. 246-246
Open Access | Times Cited: 46
Protein-Based Adjuvants for Vaccines as Immunomodulators of the Innate and Adaptive Immune Response: Current Knowledge, Challenges, and Future Opportunities
Diego A. Díaz-Dinamarca, Michelle L. Salazar, Byron N. Castillo, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1671-1671
Open Access | Times Cited: 36
Insight into potent TLR2 inhibitors for the treatment of disease caused by Mycoplasma pneumoniae based on machine learning approaches
Muhammad Ishfaq, Zia-ur Rahman, Muhammad Aamir, et al.
Molecular Diversity (2022) Vol. 27, Iss. 1, pp. 371-387
Closed Access | Times Cited: 33
Small-Molecule Modulators Targeting Toll-like Receptors for Potential Anticancer Therapeutics
Jiayu Wang, Jifa Zhang, Jiaxing Wang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 10, pp. 6437-6462
Closed Access | Times Cited: 18
Toll-like receptor agonists as cancer vaccine adjuvants
Donghwan Jeon, Ethan C. Hill, Douglas G. McNeel
Human Vaccines & Immunotherapeutics (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 15
Immunomodulatory Peptides as Vaccine Adjuvants and Antimicrobial Agents
Shiva Hemmati, Zahra Saeidikia, Hassan Seradj, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 201-201
Open Access | Times Cited: 6
Structure-activity relationship in NOD2 agonistic muramyl dipeptides
Aarzoo Kamboj, Madhuri T. Patil, Nikolai Petrovsky, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116439-116439
Closed Access | Times Cited: 5
Utilizing the subtractive proteomics approach to design ensemble vaccine against Candida lusitaniae for immune response stimulation; a bioinformatics study
Habiba Naz, Rimsha Timotheous, M. Sarwar, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0316264-e0316264
Open Access
Lactobacillus delbrueckii Alleviate Oxidative Stress and Intestinal Injuries by Activating TLR2 and TLR4 Expressions in IPEC-J2 Cells
Fengming Chen, Shu Wu, Xiaoyu Wang, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access
The influence of component structural arrangement on peptide vaccine immunogenicity
Nedaa Alharbi, Mariusz Skwarczyński, István Tóth
Biotechnology Advances (2022) Vol. 60, pp. 108029-108029
Closed Access | Times Cited: 23
Insights into therapeutic peptides in the cancer-immunity cycle: Update and challenges
Xiao-kun Zhang, Ye Wu, Jia-Yi Lin, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3818-3833
Open Access | Times Cited: 4
Development of Multi-epitope mRNA Vaccine against Clostridioides difficile Using Reverse Vaccinology and Immunoinformatics Approaches
Caixia Tan, Yuanyuan Xiao, Ting Liu, et al.
Synthetic and Systems Biotechnology (2024) Vol. 9, Iss. 4, pp. 667-683
Open Access | Times Cited: 4
Structural evolution of toll-like receptor 7/8 agonists from imidazoquinolines to imidazoles
Deepender Kaushik, Arshpreet Kaur, Nikolai Petrovsky, et al.
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 7, pp. 1065-1120
Open Access | Times Cited: 28
Small molecule modulators of immune pattern recognition receptors
Taku Tsukidate, Charles W. Hespen, Howard C. Hang
RSC Chemical Biology (2023) Vol. 4, Iss. 12, pp. 1014-1036
Open Access | Times Cited: 11
Revisiting Coley’s Toxins: Immunogenic Cardiolipins from Streptococcus pyogenes
Yern‐Hyerk Shin, Sunghee Bang, Sung‐Moo Park, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 39, pp. 21183-21188
Open Access | Times Cited: 10
Design, Synthesis, and Structure–Activity Relationship of N-Aryl-N′-(thiophen-2-yl)thiourea Derivatives as Novel and Specific Human TLR1/2 Agonists for Potential Cancer Immunotherapy
Zhipeng Chen, Lina Zhang, Junjie Yang, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 11, pp. 7371-7389
Closed Access | Times Cited: 25
Modulation of the Adjuvant Potential of Imidazoquinoline-Based TLR7/8 Agonists via Alum Adsorption
Kushvinder Kumar, Yoshikazu Honda‐Okubo, Isaac G. Sakala, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 10, pp. 1677-1684
Closed Access | Times Cited: 2
Genetic analysis of potential biomarkers and therapeutic targets in neuroinflammation from sporadic Creutzfeldt–Jakob disease
Yajing Cheng, Ting Chen, Jun Hu
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Structure−Activity Relationships Towards the Identification of High-Potency Selective Human Toll-Like Receptor-7 Agonist
Deepender Kaushik, Arshpreet Kaur, Madhuri Patil, et al.
(2024)
Open Access | Times Cited: 1
Nanoparticles as Delivery Systems for Antigenic Saccharides: From Conjugation Chemistry to Vaccine Design
Marie-Jeanne Archambault, Laetitia Mwadi Tshibwabwa, Mélanie Côté‐Cyr, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1290-1290
Open Access | Times Cited: 1
Toll-like receptor-7/8 agonist kill Leishmania amazonensis by acting as pro-oxidant and pro-inflammatory agent
Deepender Kaushik, Juliana T. Granato, Gilson Costa Macedo, et al.
Journal of Pharmacy and Pharmacology (2021) Vol. 73, Iss. 9, pp. 1180-1190
Open Access | Times Cited: 11
Combined delivery of TLR2 and TLR7 agonists by Nanostructured lipid carriers induces potent vaccine adjuvant activity in mice
Arshpreet Kaur, Rohini Kanwar, Deepender Kaushik, et al.
International Journal of Pharmaceutics (2021) Vol. 613, pp. 121378-121378
Closed Access | Times Cited: 11
Stereoisomeric Pam2CS based TLR2 agonists: synthesis, structural modelling and activity as vaccine adjuvants
Arshpreet Kaur, Sakshi Piplani, Deepender Kaushik, et al.
RSC Medicinal Chemistry (2022) Vol. 13, Iss. 5, pp. 622-637
Open Access | Times Cited: 7
Next-Generation Diprovocims with Potent Human and Murine TLR1/TLR2 Agonist Activity That Activate the Innate and Adaptive Immune Response
Ming‐Hsiu Yang, Jamie L. Russell, Yuto Mifune, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 13, pp. 9230-9252
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top